NEWS: "Hot Off the Press"
- Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer
- Green Leaf Innovations, Inc. Achieves Over 2,200% Revenue Growth Year-Over-Year
- Safety Shot Third Quarter 2024 Earnings: US$0.21 loss per share (vs US$0.26 loss in 3Q 2023)
- Safety Shot Expands Retail Footprint with Major Grocery Chain in US Southwest
- Sure Shot, the Revolutionary Alcohol-Reducing Beverage, Launches in USA Today’s Best Grocery Store in America
- Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023
- Safety Shot Reports Transformative Third Quarter 2024: Rebranding, Strategic Partnerships, and Expanded Distribution Drive Growth
- Green Leaf Innovations, Inc. Engages Solutions Group Accounting Firm to Support Strategic Growth and Financial Precision
- Safety Shot Expands Reach in Metro Chicago with New Distribution Agreement
- Genprex Collaborators Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting
- Category V Biotech, Inc. Expands Portfolio with Acquisition of FreddyCo, LLC and Miami FL Distribution, LLC
- Renovaro Issues Shareholder Letter and Provides Corporate Update
- Safety Shot Expands Distribution to Chicagoland Grocery Stores
- Genprex to Participate in 2024 BIO Europe Conference
- Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma
- Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive
- Green Leaf Innovations, Inc. Announces Progress on Q3 Consolidation and Strategic
- Cytta Corp. Announces Growing Utilization of CyttaCOMMS by Florida and Texas Law Enforcement Agencies
- RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
- Renovaro Announces Strategic Restructuring and Leadership Transition
- Genprex advances to highest dose in Phase I Acclaim-3 trial of Reqorsa
- Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination with Tecentriq® in Extensive Stage Small Cell Lung Cancer
- Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy at the 2024 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
- Safety Shot, the world's first clinically proven alcohol reducer, rebrands as Sure Shot and unveils a bold new look, focusing on 4-ounce bottles and powder stick packs
- Safety Shot, the world’s first clinically proven alcohol reducer, rebrands as Sure Shot and unveils a bold new look, focusing on 4-ounce bottles and powder stick packs
- Green Leaf Innovations CEO to Discuss Acquisition, Restructuring, and Industry Trends on JRCStockTalk Live
- Genprex Collaborators to Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting
- Category V Biotech, Inc. (c/k/a 4Cable TV International, Inc.) Announces: Strategic Acquisition
- Safety Shot’s Game Changing Blood Alcohol Reduction Beverage to Hit 7-Eleven Stores in Chicago
- Green Leaf Innovations, Inc. Completes Acquisition of SOFLO Wholesaler Group, Inc.
- The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H./Chief Scientist, Director, and Founder, NRx Pharmaceuticals
- Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Therapies for Cancer and Diabetes
- Why Cytta Corp is the Smartest Investment in the Exploding $33.5 Billion Safety Market
- Top 5 Challenges in Personal and Institutional Security Today—And How Cytta Corp is Solving Them
- How CyttaCARES is Revolutionizing School Safety
- Safety Shot Partners with Launchpad to Tap into the Large and Influential College Student Market
- PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
- International Endeavors Corp. Announces Corporate Update
- Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
- Cytta Corp. and bSafe Form Strategic Alliance to Launch Consumer Model for CyttaCARES Crisis Alert and Emergency Response System
